Rohto Pharmaceutical Co's total assets for Q1 2024 were ¥408.73B, an increase of 18.07% from the previous quarter. RPHCF total liabilities were ¥151.49B for the fiscal quarter, a 52.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.